slanDCs in carcinoma-draining lymph nodes.
Dendritic cells (DCs) are known to initiate adaptive immune responses against malignant cells. However, the role in anticancer immunosurveillance of 6-sulfo LacNAc-expressing DCs (slanDCs), a distinct population of circulating and tissue-resident pro-inflammatory DCs, is unclear. We have recently demonstrated the involvement of slanDCs in nodal immune responses against carcinoma cells.
Department of Molecular and Translational Medicine; Section of Pathology; University of Brescia; Brescia, Italy ; Department of Pathology and Immunology; Washington University School of Medicine; Saint Louis, MO USA.
William
W
Vermi
Department of Molecular and Translational Medicine; Section of Pathology; University of Brescia; Brescia, Italy.
Silvia
S
Lonardi
Department of Molecular and Translational Medicine; Section of Pathology; University of Brescia; Brescia, Italy.
Mattia
M
Bugatti
Department of Pathology and Diagnostics; Section of General Pathology; University of Verona; Verona, Italy.
Federica
F
Calzetti
Department of Pathology and Diagnostics; Section of General Pathology; University of Verona; Verona, Italy.
Alessandra
A
Micheletti
Department of Pathology and Diagnostics; Section of General Pathology; University of Verona; Verona, Italy.
Marco A
MA
Cassatella
carcinoma; slanDCs; tumor-draining lymph nodes